PHARMA - Relationships

Relationships Table

Entities - Color - Target Drug Disease Lo Med Hi
Word 1
Word 1 Count
CAT1
CAT2
Word 2
Word 2 Count
Co-occurrence
Occurence-Centile
Correlation
Overlap-Metric
G-Metric
Epidermal Growth Factor Receptor 24,772 Target Disease Bone Disorder 716 1 0.00 -1.00 0.00 0.54
Epidermal Growth Factor Receptor 24,772 Target Disease Scars 12,872 9 0.00 -1.00 0.00 0.53
Epidermal Growth Factor Receptor 24,772 Target Disease Hyperthyroidism 16,816 1 0.00 -1.00 0.00 0.46
Epidermal Growth Factor Receptor 24,772 Target Target Androgen Receptor 12,918 146 0.01 -0.99 0.01 0.64
Epidermal Growth Factor Receptor 24,772 Target Target Endostatin 1,599 9 0.00 -1.00 0.01 0.58
Epidermal Growth Factor Receptor 24,772 Target Disease Bronchitis 18,336 11 0.00 -1.00 0.00 0.53
Epidermal Growth Factor Receptor 24,772 Target Disease Seizure 44,685 4 0.00 -1.00 0.00 0.47
Epidermal Growth Factor Receptor 24,772 Target Disease Thrombocytopenia 35,805 57 0.00 -1.00 0.00 0.56
Epidermal Growth Factor Receptor 24,772 Target Disease Non Small Cell Lung Cancer 28,563 2,827 0.11 -0.89 0.11 0.78
Epidermal Growth Factor Receptor 24,772 Target Target Alpha-2a Adrenergic Receptor 188 1 0.00 -1.00 0.01 0.57
Epidermal Growth Factor Receptor 24,772 Target Target Myeloperoxidase 16,181 7 0.00 -1.00 0.00 0.52
Epidermal Growth Factor Receptor 24,772 Target Disease Diabetes 332,602 91 0.00 -1.00 0.00 0.50
Epidermal Growth Factor Receptor 24,772 Target Disease Rosacea 2,042 3 0.00 -1.00 0.00 0.54
Epidermal Growth Factor Receptor 24,772 Target Disease Anorexia Nervosa 9,687 1 0.00 -1.00 0.00 0.48
Epidermal Growth Factor Receptor 24,772 Target Target Glyceraldehyde 3-Phosphate Dehydrogenase 5,919 9 0.00 -1.00 0.00 0.55
Epidermal Growth Factor Receptor 24,772 Target Target Estrogen Receptor Beta 1,924 22 0.00 -0.99 0.01 0.61
Epidermal Growth Factor Receptor 24,772 Target Target Glucocorticoid Receptor 10,306 18 0.00 -1.00 0.00 0.56
Epidermal Growth Factor Receptor 24,772 Target Target CCL19 658 2 0.00 -1.00 0.00 0.56
Epidermal Growth Factor Receptor 24,772 Target Target CXCL16 341 2 0.00 -1.00 0.01 0.57
Epidermal Growth Factor Receptor 24,772 Target Disease Stomach Cancer 5,629 10 0.00 -1.00 0.00 0.56
Epidermal Growth Factor Receptor 24,772 Target Disease Sweating 6,326 2 0.00 -1.00 0.00 0.51
Epidermal Growth Factor Receptor 24,772 Target Disease Allergies 10,264 2 0.00 -1.00 0.00 0.49
Epidermal Growth Factor Receptor 24,772 Target Disease Thromboembolism 23,698 9 0.00 -1.00 0.00 0.51
Epidermal Growth Factor Receptor 24,772 Target Target BLK 255 1 0.00 -1.00 0.00 0.56
Epidermal Growth Factor Receptor 24,772 Target Disease Muscle Pain 2,475 1 0.00 -1.00 0.00 0.51
Epidermal Growth Factor Receptor 24,772 Target Disease Hormone Replacement Therapy 11,020 9 0.00 -1.00 0.00 0.54
Epidermal Growth Factor Receptor 24,772 Target Disease Acne 11,364 83 0.00 -0.99 0.01 0.61
Epidermal Growth Factor Receptor 24,772 Target Target CD4 112,219 56 0.00 -1.00 0.00 0.52
Epidermal Growth Factor Receptor 24,772 Target Target DDR2 194 9 0.00 -0.98 0.05 0.62
Epidermal Growth Factor Receptor 24,772 Target Target 3-Phosphoinositide-Dependent Protein Kinase 1 230 3 0.00 -0.99 0.01 0.59
Epidermal Growth Factor Receptor 24,772 Target Target High Affinity Nerve Growth Factor Receptor 47 1 0.00 -0.99 0.02 0.59
Epidermal Growth Factor Receptor 24,772 Target Drug Acamprosate Calcium (Campral)- FDA 30 1 0.00 -0.98 0.03 0.60
Epidermal Growth Factor Receptor 24,772 Target Target Cytokeratin 20 847 13 0.00 -0.99 0.02 0.61
Epidermal Growth Factor Receptor 24,772 Target Disease Poisoning 53,779 5 0.00 -1.00 0.00 0.47
Epidermal Growth Factor Receptor 24,772 Target Disease Chills 3,046 7 0.00 -1.00 0.00 0.56
Epidermal Growth Factor Receptor 24,772 Target Disease Sedimentation Rate 11,455 1 0.00 -1.00 0.00 0.47
Epidermal Growth Factor Receptor 24,772 Target Disease Burns 26,206 5 0.00 -1.00 0.00 0.49
Epidermal Growth Factor Receptor 24,772 Target Target Artemin 184 1 0.00 -1.00 0.01 0.57
Epidermal Growth Factor Receptor 24,772 Target Disease Obesity 138,233 42 0.00 -1.00 0.00 0.51
Epidermal Growth Factor Receptor 24,772 Target Disease Deep Vein Thrombosis 10,952 3 0.00 -1.00 0.00 0.50
Epidermal Growth Factor Receptor 24,772 Target Disease Hearing Loss 30,622 7 0.00 -1.00 0.00 0.50
Epidermal Growth Factor Receptor 24,772 Target Disease Carcinoma 433,099 4,400 0.04 -0.90 0.18 0.64
Epidermal Growth Factor Receptor 24,772 Target Disease Myasthenia Gravis 11,268 4 0.00 -1.00 0.00 0.51
Epidermal Growth Factor Receptor 24,772 Target Disease Sunburn 1,669 1 0.00 -1.00 0.00 0.52
Epidermal Growth Factor Receptor 24,772 Target Disease Overactive Bladder 3,492 1 0.00 -1.00 0.00 0.50
Epidermal Growth Factor Receptor 24,772 Target Disease Cervical Cancer 28,286 112 0.00 -1.00 0.00 0.60
Epidermal Growth Factor Receptor 24,772 Target Drug Abilify (Aripiprazole)- FDA 71 1 0.00 -0.99 0.01 0.58
Epidermal Growth Factor Receptor 24,772 Target Disease Endometriosis 16,342 18 0.00 -1.00 0.00 0.55
Epidermal Growth Factor Receptor 24,772 Target Disease Metastatic Breast Cancer 9,288 568 0.04 -0.96 0.06 0.71
Epidermal Growth Factor Receptor 24,772 Target Target ASK1 762 5 0.00 -1.00 0.01 0.58